SCHEMBL4989494

SCHEMBL4989494

O[C@@H](c1ccc(Br)cc1)C(F)F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
CYP2A6 P11509 1/20 0.40
CYP1A2 P05177 1/20 0.39
ALOX15 P16050 1/20 0.38
HTR2A P28223 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP19A1 P11511 4/20 0.35
CYP2C19 P33261 1/20 0.34
ALOX5 P09917 1/20 0.34
CNR1 P21554 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TSHR P16473 1/20 0.33
CFTR P13569 1/20 0.33
IGF1R P08069 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11578 1.00 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3CYP2A6CYP1A2
SCHEMBL2131604 1.00 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3CYP2A6CYP1A2
SCHEMBL4498309 0.93 ALDH1A1 (0.41) SLC6A2SLC6A4SLC6A3CYP2A6CYP1A2
SCHEMBL5011306 0.93 ALDH1A1 (0.41) SLC6A2SLC6A4SLC6A3CYP2A6CYP1A2
SCHEMBL11602636 0.84 CYP2A6 (0.50) SLC6A2SLC6A4SLC6A3CYP2A6CYP1A2
SCHEMBL28263800 0.79 CYP2A6 (0.44) SLC6A2SLC6A4SLC6A3CYP2A6CYP1A2
SCHEMBL23232284 0.77 IDO1 (0.41) CYP19A1
SCHEMBL7073627 0.77 ESR1 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2ALOX15
SCHEMBL17014700 0.75 TYR (0.41) ALOX15HTR2ACYP2C19TSHR
SCHEMBL9732281 0.75 CHRNA7 (0.46) ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407959-B2 Cathepsin cysteine protease inhibitors MERCK FROSST CANADA & CO. (CA) 2008-08-05 US disclosed
US-20070293578-A1 Cathepsin Cysteine Protease Inhibitors GAUTHIER JACQUES Y 2007-12-20 US disclosed
US-20060111440-A1 Cathepsin cysteine protease inhibitors MERCK CANADA INC. (CA) 2006-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111440-A1 Cathepsin cysteine protease inhibitors CTSB, CTSS, CTSZ SLC6A2 4308/4885SLC6A4 4386/4885SLC6A3 4059/4885
US-20070293578-A1 Cathepsin Cysteine Protease Inhibitors CTSB, CTSS, CTSE SLC6A2 4322/4885SLC6A4 4027/4885SLC6A3 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.